We are analyzing https://link.springer.com/article/10.1186/s40169-017-0181-2.

Title:
A perspective on multi-target drug discovery and design for complex diseases | Clinical and Translational Medicine
Description:
Diseases of infection, of neurodegeneration (such as Alzheimer’s and Parkinson’s diseases), and of malignancy (cancers) have complex and varied causative factors. Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds. Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done. These approaches depend on the prior identification of clinically and biologically validated targets. This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

google, scholar, pubmed, article, drug, cas, drugs, compounds, multitarget, discovery, molecular, design, target, targets, chem, activity, receptor, ligands, med, treatment, screening, docking, receptors, binding, cns, computational, development, approved, central, diseases, chemical, disease, virtual, inhibitors, methods, brain, approaches, approach, biological, lead, effects, molecules, inhibitor, ligand, multiple, identification, analysis, alzheimers, potential, combination,

Topics {✒️}

β1-adrenergic g-protein-coupled receptor n-methyl-d-aspartate glutamate receptors methyl]-n-methylprop-2-yn-1-amine hybrids bautista-aguilera om dopamine d-3 receptor-preferring article download pdf protein-coupled receptor database n-methylprop-2-yn-1-amine serotonin-dopamine activity modulator ns3/4a protease inhibitor nonsteroidal anti-inflammatory drugs multi-kinase inhibitors emerged structure-based virtual screening pathway-target-drug-disease relationships athletic performance-enhancing substances predicting p-glycoprotein efflux extending cell-based assays pan-kinase inhibitor staurosporine multipotent tacrine-dihydropyridine hybrids pharmacophore-based virtual screening cheminformatics-based target identification ligand-based virtual screening p-glycoprotein efflux properties small-scale academic laboratories quantitative structure-exposure relationships central nervous system sg/group/ttd/ttd 1-methyl-1h-indol-2-yl multi-target drugs emerge predicting multi-target bioactivities central beta-amyloid computer-aided drug discovery quantitative structure–activity relationship n-substituted piperidin-4-yl multi-target ligands intended structure-brain exposure relationships docked ligand-target complexes radioiodine-refractory thyroid cancers designing multi-target drugs structure-based drug discovery anti-cancer drug discovery multi-target-directed ligands including pan-cdks inhibitors multi-target drug discovery model gene-environment interactions grid-based molecular docking pharmacophore-based docking program post-synaptic d2 receptors targeting cyclin-dependent kinases previous 3d-qsar analyses

Questions {❓}

Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M et al (2014) QSAR modeling: where have you been?
Hughes RE, Nikolic K, Ramsay RR (2016) One for all?
Peters JU (2013) Polypharmacology—foe or friend?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A perspective on multi-target drug discovery and design for complex diseases
         description:Diseases of infection, of neurodegeneration (such as Alzheimer’s and Parkinson’s diseases), and of malignancy (cancers) have complex and varied causative factors. Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds. Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done. These approaches depend on the prior identification of clinically and biologically validated targets. This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.
         datePublished:2018-01-17T00:00:00Z
         dateModified:2018-01-17T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1186/s40169-017-0181-2
         keywords:
            Multi-target drugs
            Neurodegeneration
            Cancer
            Cheminformatics
            Virtual screening
            Biological assays
            Medicine/Public Health
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig4_HTML.gif
         isPartOf:
            name:Clinical and Translational Medicine
            issn:
               2001-1326
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rona R. Ramsay
               affiliation:
                     name:Biomedical Sciences Research Complex, University of St Andrews
                     address:
                        name:Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Marija R. Popovic-Nikolic
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katarina Nikolic
               affiliation:
                     name:University of Belgrade
                     address:
                        name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elisa Uliassi
               affiliation:
                     name:Alma Mater Studiorum-Bologna University
                     address:
                        name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Maria Laura Bolognesi
               affiliation:
                     name:Alma Mater Studiorum-Bologna University
                     address:
                        name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A perspective on multi-target drug discovery and design for complex diseases
      description:Diseases of infection, of neurodegeneration (such as Alzheimer’s and Parkinson’s diseases), and of malignancy (cancers) have complex and varied causative factors. Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds. Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done. These approaches depend on the prior identification of clinically and biologically validated targets. This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.
      datePublished:2018-01-17T00:00:00Z
      dateModified:2018-01-17T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1186/s40169-017-0181-2
      keywords:
         Multi-target drugs
         Neurodegeneration
         Cancer
         Cheminformatics
         Virtual screening
         Biological assays
         Medicine/Public Health
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40169-017-0181-2/MediaObjects/40169_2017_181_Fig4_HTML.gif
      isPartOf:
         name:Clinical and Translational Medicine
         issn:
            2001-1326
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rona R. Ramsay
            affiliation:
                  name:Biomedical Sciences Research Complex, University of St Andrews
                  address:
                     name:Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Marija R. Popovic-Nikolic
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katarina Nikolic
            affiliation:
                  name:University of Belgrade
                  address:
                     name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elisa Uliassi
            affiliation:
                  name:Alma Mater Studiorum-Bologna University
                  address:
                     name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Maria Laura Bolognesi
            affiliation:
                  name:Alma Mater Studiorum-Bologna University
                  address:
                     name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Clinical and Translational Medicine
      issn:
         2001-1326
      volumeNumber:7
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Biomedical Sciences Research Complex, University of St Andrews
      address:
         name:Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:University of Belgrade
      address:
         name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
         type:PostalAddress
      name:Alma Mater Studiorum-Bologna University
      address:
         name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
         type:PostalAddress
      name:Alma Mater Studiorum-Bologna University
      address:
         name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rona R. Ramsay
      affiliation:
            name:Biomedical Sciences Research Complex, University of St Andrews
            address:
               name:Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Marija R. Popovic-Nikolic
      affiliation:
            name:University of Belgrade
            address:
               name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Katarina Nikolic
      affiliation:
            name:University of Belgrade
            address:
               name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
               type:PostalAddress
            type:Organization
      name:Elisa Uliassi
      affiliation:
            name:Alma Mater Studiorum-Bologna University
            address:
               name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
               type:PostalAddress
            type:Organization
      name:Maria Laura Bolognesi
      affiliation:
            name:Alma Mater Studiorum-Bologna University
            address:
               name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK
      name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
      name:Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
      name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy
      name:Department of Pharmacy and Biotechnology, Alma Mater Studiorum-Bologna University, Bologna, Italy

External Links {🔗}(337)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.96s.

LINK . SPRINGER . COM {}